The four COVVI-19 vaccines, available on the French market, are safe, once again provides ANSM.
- The results of pharmacovigilance surveys again show that the COVVI-19 vaccines available in France are safe.
- The study focused on Cumirnaty de Pfizer, Spikevax by Moderna, Nuvaxovid de Novavax and Vidprevtyn Beta from Sanofi/GSK.
- No link between Charcot’s disease and COVID-19 vaccines has been established.
After having compiled all the data collected by the regional pharmacovigilance centers (CRPV) between January 2023 and February 2024, the ANSM reaffirms once again that the four vaccines against COVVI-19 available in France-that is to say Cumirnaty de Pfizer, Spikevax by Moderna, Nuvaxovid de Novavax and Vidprevtyn Beta de Sanofi/GSK – are safe.
“COVVI-19 vaccines are sure”
“Over 152 million doses“Anti-Cavid vaccines”were administered “ in France and about “163,000 reports of suspected potential adverse effects have been recorded”explained Mehdi Benkebil, director of surveillance of the ANSM, at AFP in the preamble to the publication of the report. “All these cases have been the subject of analyzes at regional and national level. For comparison, annually, we receive around 40,000 cases for all drugs”.
THE analyzes of all of these data thus confirm “The safety profile of Comirnaty, Spikevax, Nuvaxovid and Vidprevtyn Beta against COVVI-19”. An investigation also looked solely at pregnant and breastfeeding women and “No disturbing data has been noted to date”assure the authors in their report.
COVVI-9 vaccine: no link with Charcot’s disease
“The majority of the undesirable effects declared are not serious”add experts to their press release. If links have been established between Vaccines against COVVI-19 and rare cases of peripheral facial paralysis (partial loss of the functioning of part of the facials), myocarditis/pericarditis, significant menstrual bleeding and erythema Polymorphic (inflammatory reaction, characterized by skin lesions), the teams, on the other hand, identified any link between Charcot disease and the doses used to combat the coronavirus.
